Dimefluthrin

Synonyms: 四氟甲醚菊酯
Dimefluthrin 是一种杀虫剂,对入侵红火蚁工蚁具有接触毒性,可在其工蚁间发生水平传递并导致接受毒物的工蚁出现继发性死亡,同时作为一种神经发育毒物,它可降低乙酰胆碱酯酶 (acetylcholinesterase) 活性并损害神经递质。
产品编号: MS-R83219 CAS No.: 271241-14-6 分子式: C19H22F4O3 分子量: 374.38
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Dimefluthrin 是一种杀虫剂,对入侵红火蚁工蚁具有接触毒性,可在其工蚁间发生水平传递并导致接受毒物的工蚁出现继发性死亡,同时作为一种神经发育毒物,它可降低乙酰胆碱酯酶 (acetylcholinesterase) 活性并损害神经递质。

生物实验数据

生物活性 Dimefluthrin is an insecticide that exhibits contact toxicity against red imported fire ant workers, can be horizontally transferred among these workers and cause secondary mortality in workers receiving the toxicant, and acts as a neurodevelopmental toxicant that reduces acetylcholinesterase activity and impairs neurotransmitters.
IC50 & Target

AChE

 

体外研究
(In Vitro)

Dimefluthrin (0.325-12 μg/mL; 24 h) 可高效灭杀大型红火蚁工蚁,其 LD50 为 1.57 ng/ant。
Dimefluthrin 可快速击倒大型红火蚁工蚁,其 KT50 值在 0.5 至 5 μg/mL 之间。
Dimefluthrin (30-60 μg/mL) 溶液可在红火蚁 (Solenopsis invicta) 工蚁之间有效水平传递;在 60 μg/mL 浓度下,可使二级受药蚁在 24 h 内死亡率 >98%,三级受药蚁在 48 h 内死亡率最高达 99.33%。

体内研究
(In Vivo)

Dimefluthrin (0.2-0.8 μg/mL; 72 h) 会在斑马鱼幼鱼中诱导浓度依赖性的神经发育损伤、血管功能障碍、神经传递紊乱以及运动行为抑制;在低至 0.2 μg/mL 的剂量下即可观察到显著效应,在最高测试剂量 0.8 μg/mL 下可几乎完全抑制 CNS 轴突束的生长,且这些运动效应可被 Bromocriptine (MS-A48164) 逆转。

Animal Model: Danio rerio larvae (5 days post-fertilization larvae)
Dosage: 0.2, 0.4, 0.8 μg/mL
Administration: waterborne; continuous; 72 h (solution replacement every 24 h)
Result: Caused concentration-dependent inhibition of olfactory bulb, telencephalon, mesencephalon, medulla oblongata, optic parietal region, and hindbrain neuron development.
Reduced relative length of CNS axon tracts by ~50% at 0.4 μg/mL (P < 0.01) and ~90% at 0.8 μg/mL (P < 0.01).
Widened hindbone spacing in a concentration-dependent manner, with a ~3-fold increase at 0.8 μg/mL (P < 0.01).
Reduced relative fluorescence intensity of overall brain vasculature by ~20% at 0.2 μg/mL (P < 0.05), ~50% at 0.4 μg/mL (P < 0.01), and ~80% at 0.8 μg/mL (P < 0.01).
Widened intersegmental vessel spacing by ~70% at 0.8 μg/mL (P < 0.01), with no significant changes at 0.2 or 0.4 μg/mL.
Reduced relative fluorescence intensity of cerebral veins by ~50% at 0.4 μg/mL (P < 0.01) and ~70% at 0.8 μg/mL (P < 0.01), with no significant change at 0.2 μg/mL.
Caused disorganized, sparse brain cell distribution with vacuolization, blurred brain structure borders, and tail muscle cell vacuolization at all tested doses.
Induced coin-shaped skeletal fiber arrangements in the notochord at 0.8 μg/mL.
Decreased acetylcholinesterase activity in a concentration-dependent manner, with significant decreases at all tested doses (P < 0.01).
Dysregulated expression of neurodevelopment-related genes, including upregulation of elavl3 and downregulation of syn2a, dat, mao, and dr1 in a concentration-dependent manner.
Upregulated comt and th gene expression by ~2.2-fold and ~2.8-fold, respectively, at 0.8 μg/mL (P < 0.01).
Induced concentration-dependent suppression of locomotor activity, with total swimming distance reduced by ~30% at 0.2 μg/mL, ~50% at 0.4 μg/mL (P < 0.01), and ~80% at 0.8 μg/mL (P < 0.01).
Reduced swimming speed and acceleration in a concentration-dependent manner.
Restored total swimming distance, speed, and acceleration to levels near those of untreated controls when co-exposed with Bromocriptine for dimefluthrin-induced locomotor suppression.

化学信息

分子量 374.38
分子式 C19H22F4O3
CAS No. 271241-14-6
别名 四氟甲醚菊酯

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础